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Background: Muscle metastases (MM) from solid tumours are rare. The aim of this study was to describe
radiological features of MM, and to compare their patterns in different malignancies.
Methods: A retrospective search in the statistical database of our institution revealed 61 cases of MM. Additionally,
a retrospective search in Pubmed database was performed. Together with our cases the present analysis comprises
461 patients (682 MM).
Results: MM derived from the following malignancies: lung cancer (25.1%), gastrointestinal tumours (21.0%), and
urological tumours (13.2%). Other neoplasias with MM were rare. MM were localised most frequently in the thigh
muscles, the extraocular musculature, and the gluteal and paravertebral muscles. The localisation of MM was
different in several primary malignancies.
On computed tomography (CT), five different patterns of MM occurred: masses with homogeneous contrast
enhancement (type I, 46.5%), abscess-like lesions (type II, 27.7%), diffuse infiltration with muscle swelling (type III,
18.1%), intramuscular calcifications (type IV, 6.5%), or MM presented as intramuscular bleeding (type V, 1.2%). MM
from several primary tumours manifested with different CT patterns.
On MRI, most MM were hyperintense in comparison to unaffected musculature in T2 weighted images and hypo- to
isointense on T1 weighted images with a heterogeneous enhancement. There were no differences in MRI features of
MM in different primary tumours. On ultrasound, most MM were hypoechoic. On positron emission tomography, MM
presented as focally abnormal intramuscular uptake.
Conclusion: MM present with a broad spectrum of radiological features. Different CT imaging findings of MM were
observed in different primary tumours. The localisation of MM also varies with different primary malignancies.
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Primary tumoursBackground
Muscle metastases (MM) from solid tumours are rare.
The prevalence of MM varies from 0.03% to 5.6% in aut-
opsy series [1-4], and from 1.2% to 1.8% in radiological
series [5,6].
This is due to the fact that muscles have several
protective mechanisms against metastatic invasion [4,7].
According to the literature, the musculature produces sev-
eral biochemical anti-tumour factors, and it can damage* Correspondence: alex.surow@medizin.uni-halle.de
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unless otherwise stated.tumour cells biomechanically [7-10]. Previously, several
radiological features of MM were reported [6,11-13].
According to Pretorius and Fishman, the most com-
mon appearance of MM on computed tomography
(CT) was an isolated intramuscular mass with central
low attenuation and rim enhancement [14]. However, in
other reports, masses with homogeneous enhancement
were the most frequent pattern of MM [6]. In addition,
other imaging features, such as intramuscular calcifica-
tions, muscle infiltration and muscle bleeding were also
documented [6,11,12,15].
As reported previously, on magnetic resonance im-
aging (MRI), MM were hypointense on T1 weightedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Primary malignancies
Tumours n %
Lung cancer 116 25,2
Gastrointestinal tumours small bowel carcinoma 1 21.0





carcinoma of pancreas 5
Urological tumours renal cell carcinoma 38 13,2
urothel carcinoma 23





carcinoma of cervix uteri 18




Carcinoma of cutis 2
Thyroid gland carcinoma 17 3,7
Others carcinoma of larynx 4 2,8
neuroblastoma 2
pleural mesothelioma 3
parotid gland carcinoma 1
carcinoma of pharynx 2
tongue carcinoma 1
Carcinoid 8 1,7
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images, with marked enhancement after contrast admin-
istration [5,12,15,16]. However, hyperintense lesions on
T1w images and slightly enhancing lesions have also
been described in the literature [17].
It must be presumed that radiological patterns of MM
vary in different primary tumours. However, up to now, it
was not examined whether some entities are more likely to
cause a certain radiological pattern of MM than others.
Therefore, the purpose of this study was to describe
radiological features of muscle metastases, and to com-
pare their patterns in different malignancies.
Methods
Patients and literature review
A retrospective search in the statistical database of our
institution from January 2000 to December 2007 re-
vealed 61 cases of MM from solid malignancies.
Additionally, a retrospective search in Pubmed data-
base using the keywords “muscle metastasis”, “muscle
metastases”, “intramuscular metastasis”, “intramuscular
metastases” and “metastases to the musculature” was
performed. Publications in the time interval from 1990
to 2010 were considered. Secondary references were also
reviewed.
Inclusion criterion for MM lesions was a sufficient de-
scription of CT, and/or MRI, and/or sonographic and/or
PET features.
After thorough analysis 274 articles with 400 patients
were involved in the study.
Therefore, together with our 61 cases the present ana-
lysis comprises 461 patients.
Imaging
CT
In our institution 61 patients with MM were found
retrospectively. In all cases CT (Somatom Plus 4 VZ,
and Somatom Sensation 64, Siemens, Erlangen, Germany)
was performed after intravenous application of 60–140 ml
of iodinated intravenous contrast medium at a rate of 1.5-
3.5 ml/s by a power injector (Medtron GmbH, Germany),
with a scan delay of 30–90 s after onset of injection.
In the literature, CT findings of MM were available for
199 patients. Therefore, our analysis included CT find-
ings of MM in 260 patients.
MRI
In our institution, 28 patients with MM were investi-
gated by MRI. MR imaging was performed using a 1.5 T
MRI scanner (Magnetom Vision Sonata Upgrade, Siemens,
Germany). Several different scanning protocols were used
depending on lesion localisation. MRI sequences included
T2 weighted (T2w) images, fat-supressed T2w images and
T1 weighted (T1w) images.In 24 patients MR images were repeated after intraven-
ous administration of contrast medium (gadopentate dime-
glumine, Magnevist, Bayer Schering Pharma, Leverkusen,
Germany), 0.1 ml per kilogram of body weight.
70 cases with MM were acquired from the literature.
Therefore, our analysis included MRI findings of MM in
98 patients.
Ultrasound
Ultrasound was performed in one patent with MM in
our clinic. In the literature 39 cases of MM investigated
by US were reported.
PET and PET/CT
PET and PET/CT were not performed in our institution.
PET features of 28 patients with MM were acquired from
the literature.
Table 2 Localisation of the identified MM
Localisation n %
Thigh muscles 151 22.1
Extraokular muscles 102 15.0
Gluteal muscles 73 10.7
Paravertebral musculature 70 10.3
Iliopsoas muscle 69 10.1
Thoracal muscles 58 8.5
Upper arm muscles 50 7.3
Abdominal wall muscles 30 4.4
Lower leg musculature 29 4.3
Head and neck muscles 26 3.8
Fore arm muscles 24 3.5
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Statistical analysis was performed using SPSS statistical
software package (SPSS 17.0, SPSS Inc., Chicago IL, USA).
Collected data were evaluated by means of descriptive
statistics (absolute and relative frequencies). Continuous
variables were expressed as mean ± standard deviation
(SD), and categorical variables as percentages. Numbers of
events between groups were compared with a chi-square
test. Significance level was chosen to be 0.05.
Results
Primary tumours and localisation of MM
Our analysis comprises 461 patients. In these patients
682 MM were detected.
The muscle metastases derived from the following ma-
lignancies: lung cancer (25.1%), gastrointestinal tumours
(21.0%), urological tumours (13.2%), genital tumoursTable 3 Localisation of MM in frequent different primary tum
Primary tumours
AWM EoM Glu IP
Lung cancer,
LC (n = 162)
4 (2.5) 4 (2.5) vs BC
p = 0.021




CC (n = 48)
7 (14.6) vs LC
p = 0.021
1 (2.1) vs BC
p = 0.021
7 (14.6) 7 (14.6)
Stomach cancer,
SC (n = 33)
1 (3.0) 4 (12.1) vs BC
p = 0.021
6 (18.2) 2 (6.1)
Esophageal cancer,
EC (n = 46)
2 (4.3) 1 (2.2) vs BC
p = 0.021




RCC (n = 46)
4 (8.7) vs BC
p = 0.021
3 (6.5) 6 (13.0)
Urothel carcinoma,
UC (n = 37)
2 (5.4) 4 (10.8) 11 (29.7
p = 0.00
Breast cancer,
BC (n = 73)
2 (2.7) 53 (72.6) 2 (2.7) 1 (1.4)
AWM abdominal wall muscles, EoM extraocular muscles, Glu gluteal muscles, IP ilio
paravertebral muscles, Tho thoracic wall muscles, LE lower extremities muscles.(9.3%), and breast cancer (8.2%). Other neoplasias with
MM were rare (Table 1).
MM were multiple in 111 (24.1%) patients and solitary
in 350 cases (75.9%).
MM were localised most frequently in the thigh mus-
cles, the extraocular musculature, and the gluteal and
paravertebral muscles (Table 2).
Breast cancer metastasised more often into the extraocu-
lar musculature in comparison to other tumours (Table 3).
MM from lung cancer were localised frequently in the
upper and lower extremities, colorectal carcinomas metas-
tasised often into the abdominal wall musculature, urothel
carcinomas into the iliopsoas muscle, and gastric cancer
into the gluteal and lower extremities muscles (Table 3).
CT features of MM
CT images were available for 260 metastases. On these
images, five different patterns of MM were found. 46.5%
presented as round or oval masses with homogeneous
contrast enhancement (type I, Figure 1). In 27.7% of
MM type II was diagnosed. These metastases manifested
as abscess-like intramuscular lesions with central low at-
tenuation and rim enhancement (Figure 2). Type III of
MM presented as diffuse infiltration with muscle swell-
ing and inhomogeneous enhancement (Figure 3) and
was seen in 18.1%. Type IV of MM showing multiple
intramuscular calcifications (Figure 4) occurred in 6.5%.
1.2% of MM presented as intramuscular bleeding (type V,
Figure 5).
CT features of MM arising from frequent primary tu-
mours are listed in Table 4. Type II lesions occurred sig-
nificantly more often in lung cancer than in stomach
cancer (p = 0.042), breast carcinoma (p = 0.021), and renal
cell carcinoma (p = 0.02). MM from renal cell carcinomaours (more than 30 lesions per tumour)
Localisation, n (%)
HN UE PvM Tho LE
1 (0.6) 34 (21.0) vs BC
p = 0.005
20 (12.3) 24 (14.8) 50 (30.9) vs BC
p = 0.005
1 (2.1) 3 (6.3) 8 (16.7) 2 (4.2) 12 (25.0) vs BC
p = 0.009
1 (3.0) 1 (3.0) 2 (6.1) 3 (9.1) 13 (39.4) vs BC
p = 0.005
4 (8.7) 5 (10.9) 3 (6.5) 4 (8.7) 11 (23.4) vs BC
p = 0.018




2 (5.4) 3 (8.1) 1 (2.7) 14 (37.8) vs BC
p = 0.005
7 (9.6) vs BC
p = 0.009
2 (2.7) 3 (4.1) 3 (4.1)
psoas muscle, HN head and neck muscles, UE upper extremities muscles, PvM
Figure 1 Imaging findings in a 50 year old woman with known history of melanoma. (a) CT image showing an oval mass with homogeneous
contrast enhancement (type I) in the left gluteal musculature. (b) The lesion is hypointense on T1w image (spin echo pulse sequence, TR/TE: 569/11 ms).
(c) The lesion is hyperintense on T2w image (short tau inversion recovery (STIR), TR/TE: 5210/80 ms). (d) After intravenous administration of contrast
medium the lesion shows marked homogeneous enhancement (T1w spin echo with fat saturation, TR/TE: 610/12 ms).
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with urothel carcinoma (p = 0.042). Type IV MM were
seen more often in stomach cancer than in lung cancer
(p = 0.042).
The median size as determined by measuring the max-
imum diameter of the MM that presented as masses wasFigure 2 Type II metastasis in the right paravertebral musculature in
central low attenuation and rim enhancement. (b) On the T1w image (T1w fl
to the unaffected musculature. (c) On T2w image (half-Fourier acquisition turb
isointense (arrow). (d) On MRI after administration of contrast medium (T1w f
central low attenuation and rim enhancement (arrow).44.9 ± 35.9 mm. There were no significant differences be-
tween the sizes of MM depending on the primary tumour.
MRI features of MM
MRI findings were available for 98 MM. On T2W images
81.6% of the metastases were hyperintense in comparisona patient with lung carcinoma. (a) On CT, the lesion (arrow) shows
ash 2D, TR/TE: 142/2.2 ms) the lesion (arrow) is isointense in comparison
o spin echo pulse sequence, HASTE, TR/TE: 800/120 ms) the lesion is
lash 2D image with fat saturation, TR/TE: 209/2.3 ms) the lesion shows
Figure 3 MM type III in a patient with known metastatic soft tissue sarcoma. CT images before (a) and after administration of
contrast medium (b) documenting a massive hypodense enlargement of the right paravertebral musculature with inhomogeneous
enhancement (arrow).
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intense, 6.1% isointense, and 3.1% metastases were
hypointense. On T1W images 48.3% of the MM were
homogeneously isointense compared with unaffected
muscle tissue, 31.9% were hyperintense, and 19.8% were
hypointense.
After intravenous administration of contrast medium
most lesions (87.2%) showed a heterogeneous enhance-
ment. Homogeneous enhancement was seen in 12.8% of
the cases (Figures 1d, 6a). There were no differences in
MRI features of MM in different primary tumours.
Ultrasound findings of MM
US features of 40 lesions were available. 39 MM
(97.5%) were hypoechoic and one metastasis (2.5%)Figure 4 MM type IV in a patient with urinary bladder carcinoma.
CT image demonstrates multiple calcifications in the left iliopsoas
muscle (arrow).was hyperechoic (Figure 6b). Because of the small
number of MM investigated by US no further statis-
tical analysis was performed.
PET images of MM
PET features of 28 patients (40 lesions) were available.
There were 22 patients with lung cancer, 9 patients
with esophageal cancer, 2 patients with gall bladder car-
cinoma, 2 patients with renal cell carcinoma, 1 patient
with sarcoma, 1 patient with carcinoma of cervix uteri
and 1 patient with endometrial cancer. All identified
MM presented as focally abnormal intramuscular up-
take (Figure 7) with SUV ranging from 2.4 to 20.3, median
SUV 6.7 (mean SUV= 8.0 ± 4.4). Because of the smallFigure 5 MM type V in a patient with known history of
esophageal cancer. CT without intravenous administration of
contrast medium shows hyperdense areas (arrow) in the right
iliopsoas muscle.
Table 4 Comparison of CT features of MM in frequent primary tumours (more than 15 lesions)
Primary tumours CT-Type
Type I Type II Type III Type IV Type V
n (%) n (%) n (%) n (%) n (%)
Lung cancer, LC (n = 45) 13 (28.9) 23 (51.1) p = 0.042 vs SC 8 (17.8) 1 (2.2) p = 0.042 vs SC
Colonic cancer, CC (n = 27) 9 (33.3) 9 (33.3) 5 (18.5) 3 (11.1) 1 (3.7)
Stomach cancer, SC (n = 17) 7 (41.2) 1 (5.9) 5 (29.4) 4 (23.5)
Breast carcinoma, BC (n = 26) 16 (61.5) 1 (3.8) p = 0.021 vs LC 9 (34.6)
Malinant melanoma, MMe (n = 16) 9 (56.3) 5 (31.3) 2 (12.5)
Renal cell carcinoma, RCC (n = 22) 19 (86.4) p = 0.042 vs UC 2 (9.1) p = 0.02 vs LC 1 (4.6)
Urothel carcinoma, UC (n = 16) 4 (25.0) 6 (37.5) 4 (25.0) 2 (12.5)
Surov et al. Cancer Imaging 2014, 14:21 Page 6 of 8
http://www.cancerimagingjournal.com/content/14/1/21number of MM in different primary tumours investigated
by PET or PET/CT no further statistical analysis was
performed.
Discussion
Previously, some meta-analyses regarding MM were
reported [18-20]. In these publications primary tu-
mours, prevalence of MM and their localisations were
described. The number of reported lesions was up to
254 [18-20]. Our report with 461 patients/682 lesions
is the largest to date. Furthermore, this is the first
analysis of radiological patterns of MM in dependency
on primary tumours.
According to Haygood et al., most common primary
malignancies were lung cancer, sarcomas, melanoma,
renal cell carcinoma and breast cancer in decreasing
order of frequency [18]. In a previously reported mono-
center study, MM from urogenital tumours occurred
most commonly, followed by gastrointestinal tumours
and malignant melanoma [6]. In the present analysis,
lung cancer, gastrointestinal tumours, urogenital tu-
mours, and breast cancer were the most frequent pri-
mary malignant diseases.
In previous reports, most MM were localised in
the trunk musculature, lower extremities and in theFigure 6 MM in the thigh musculature in a patient with known histor
echo sequence with fat saturation, TR/TE: 615/11 ms) after contrast admini
enhancement (arrow). On ultrasound, the mass was mixed hypo- to hyperegluteal muscles [18]. Our results showed that MM were
localised most frequently in the thigh muscles, extrao-
cular musculature, gluteal and paravertebral muscles.
Furthermore, we found that several primary malignan-
cies showed different MM localisations. For example,
lung cancer tends to metastasise to the extremities,
whereas most MM from breast cancer were located in
the extraocular musculature. Urothel carcinomas me-
tastasise significantly more often into the iliopsoas
musculature. This finding may be related to the fact
that the primary tumours have different metastatic
routes. Furthermore, it must be presumed that they have
different pathophysiological mechanisms of intramuscu-
lar metastatic spread.
According to the literature, there are three important
pathophysiological mechanisms. Firstly, MM can develop
via the arterial route [4,6]. Secondly, malignant tumours
can metastasise into the musculature via venous vessels,
especially through the paravertebral venous plexus [21].
Paravertebral veins have multiple connections to the infer-
ior vena cava and the mesenterial venous system. As re-
ported previously, pelvic and abdominal malignancies
metastasise often via the paravertebral veins [21]. Thirdly,
MM can originate in intramuscular aberrant lymph nodes,
especially MM in the psoas muscle [22].y of metastatic renal cell carcinoma. (a) T1w image (turbo spin
stration shows a lobulated mass (arrow) with inhomogeneous
choic in comparison to the unaffected muscle (b).
Figure 7 Imaging findings in a patient with lung cancer. PET (a) showing focal uptake in the left gluteal musculature (arrow). CT scan
(b) detecting intramuscular masses in this area (arrow). Fusion image (c).
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lesions with homogeneous enhancement (type I). As
reported previously, these metastatic lesions should
be differentiated from several benign diseases, such
as muscle hemangioma, intramuscular ganglion, and
myxoma [23,24].
Lesions with central low attenuation and rim enhance-
ment were seen in 27.7% of MM. These lesions can be
mistaken for intramuscular abscesses [6]. However,sec-
ondary abscess formation in intramuscular metastases
has also been described [6].
Diffuse metastatic muscle infiltration was seen in 18.1%
of MM. This pattern can be misdiagnosed as muscle sar-
coma or primary/secondary muscle lymphoma [25,26].
6.6% of MM manifested as intramuscular calcifica-
tions. The cause of this neoplasm-induced intramuscular
ossification is unknown. These MM can mimic benign
muscle calcifications, which occurs in myositis ossifi-
cans, intramuscular angiomatosis, systemic sclerosis, and
calcific myonecrosis [27,28].
1.2% of MM presented with intramuscular bleeding.
This pattern of MM has been described only sporadic-
ally by now [6,29].
As seen, MM can manifest with a broad spectrum
of radiological features. Furthermore, we hypothesize
that several malignancies might produce different
metastatic patterns in the musculature. In fact, type
II lesions occurred significantly more often in lung
cancer than in stomach cancer, breast carcinoma, or
renal cell carcinoma. In contrast to other tumours,
MM from stomach cancer tend to manifest as diffuse
muscle infiltration.
On MRI, most lesions were hyperintense on T2w and
hypointense on T1w in comparison to unaffected muscu-
lature, with heterogeneous contrast enhancement. This
finding is in agreement with previous reports [5,12,15,17].
We found no differences in MRI features of MM between
different primary tumours.
Previously, US findings of MM have been reported
only in isolated case reports. Our analysis shows that on
US most MM were hypoechoic.On PET/CT, MM manifested as focal hypermetabolic
lesions. The finding corresponds well with those of
other authors [30-32]. Again, there were no differences
of PET/CT features of MM with differentprimary
malignancies.
Our study has several limitations. It is retrospective,
and most MM were acquired from the literature. Some
primary tumours/MM could not be included into the
statistical analysis because of the small number of pa-
tients/lesions. Furthermore, not every patient/lesion was
investigated by all radiological methods i.e. CT, MRI,
US, and PET/CT. These limitations can explain that only
for CT specific radiological features could be associated
with different primary tumours.
Conclusion
Our study shows that MM present with a broad spectrum
of radiological features.
CT findings of MM show differences between different
primary tumours. The localisation of MM also varies with
different primary malignancies.
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